HTA

News

Okra says AI-based drug price predictor is 90% accurate

UK artificial intelligence startup Okra Technologies has launched a new software platform that it claims can take the guesswork out of the price that can be charged for new drugs, years ahe

Views & Analysis

How does HTA for orphan drugs differ across Europe?

New research looks at the factors that speed up and slow down HTA appraisals for rare disease medicines across Europe.

Views & Analysis

Janssen: ‘Open dialogue’ needed with HTAs to improve access

The world of life sciences is changing rapidly, and the traditional ways of assessing drugs may no longer be fit for purpose.

Views & Analysis

Making real world evidence fit for purpose

Although real world evidence (RWE) is a hot topic in pharma right now, many still question whether it is acceptable to be used in regulatory decision making.

Views & Analysis